您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Blotting & Detection

BCA蛋白定量试剂盒

BCA蛋白定量法是目前常用的蛋白定量方法之一。本产品的原理是在碱性条件下,蛋白质将Cu2+还原为Cu+,Cu+与BCA试剂(Bicinchoninic Acid,二喹啉甲酸)形成紫色络合物,该络合物在562nm处有紫外吸收峰,与标准曲线对比,即可计算出待测蛋白的浓度。

生物试剂 供应商 艾碧维 ↗ 型号 AWB0104 更新 2026-10-31
参考价格区间
¥100
含税参考价,实际以配置与渠道报价为准
本条目供应商 艾碧维原厂 498个条目 进入企业主页

01产品图片

02产品简介

BCA蛋白定量法是目前常用的蛋白定量方法之一。本产品的原理是在碱性条件下,蛋白质将Cu2+还原为Cu+,Cu+与BCA试剂(Bicinchoninic Acid,二喹啉甲酸)形成紫色络合物,该络合物在562nm处有紫外吸收峰,与标准曲线对比,即可计算出待测蛋白的浓度。

03产品介绍

BCA蛋白定量法是目前常用的蛋白定量方法之一。本产品的原理是在碱性条件下,蛋白质将Cu2+还原为Cu+,Cu+与BCA试剂(Bicinchoninic Acid,二喹啉甲酸)形成紫色络合物,该络合物在562nm处有紫外吸收峰,与标准曲线对比,即可计算出待测蛋白的浓度。

BCA法快速、灵敏、稳定。以BSA(牛血清蛋白)溶液为蛋白质标准品溶液,测定范围为20~2000μg/ml。

● 在低温条件或长期保存出现沉淀时,可搅拌或37℃温育使溶解,如发现细菌污染则应丢弃。

1、 BSA蛋白质标准工作液配制:用与待测蛋白样品一致的稀释液按下表稀释BSA标准品

2、 体积比为50∶1的比例配制适量BCA工作液,充分混匀

例子:BSA标准样品个数为7个,待测样品为2个,每个样品重复3次。

(7个BSA标准品样品+2个待测品样品)×3×0.2ml=5.4ml

再根据BCA-A和BCA-B体积比50∶1的比例计算所需量。但是由于加样过程中存在误差,建议多配2个孔的量。

认真做好每一个抗体, 每一个抗体都经过反复验证!

规格明细:名称 — AWB0104-100T — AWB0104-250T — AWB0104-500T — AWB0104-2500T — storage;BCA-A — 20ml — 50ml — 100ml — 500ml — RT;BCA-B — 0.6ml — 1.5ml — 3ml — 15ml — RT;BSA Standard Solution — 0.5ml — 1ml — 2ml — 10ml — 2-8℃

规格明细:化合物 — 浓度 — 化合物 — 浓度;NP-40 — 1.0% — 葡萄糖 — 10mM;SDS — 1.0% — 蔗糖 — 1M;盐酸胍 — 4M — EDTA — 10mM;Trition X-100 — 1% — β-巯基乙醇 — 50μM;甘氨酸 — 1M — DTT — 1mM;乙酸盐 — 0.2M — 尿素 — 3M;Tris — 0.1M — DMSO — 5%;NaCl — 1M — 甘油 — 10%;HCl/NaOH — 0.1M — TES — 50mM;HEPES — 0.1M — MOPS — 50mM

Authors:Cai Xueyao, Li Weidong, Shi Wenjun, Cai Yuchen, Zhou Jianda ACS Applied Materials & Interfaces IF:10.383

In this work, a T2–T1 switchable superparamagnetic iron oxide nanoprobe with a pH/H2O2 dual response was obtained using a microemulsion method. This novel method for the controllable assembly of small iron clusters followed by their independent modification was reported, which could not be prepared by common synthetic methods. The size of the assembled nanoprobe was uniform and controllable, with a stable T2 magnetic resonance imaging (MRI) signal under a single condition. When the nanoprobe was exposed to the tumor environment, the higher H+ and H2O2 concentrations at the tumor site could dissociate the nanoprobe and redisperse into small iron clusters. When this occurred, the T2 MRI signal was converted into a T1 MRI signal, achieving specific detection of tumors by a pH/H2O2 dual-response T2–T1 MRI.

Authors:Wei Liu, Sheng-Yan Yin, Yingcai Hu, Ting Deng, Jishan Li Authors:Wu Xu, Jiang Yixia, Li Rong, Xia Yezhou, Li Feifan, Zhao Meiyun, Li Guoqing, Tan Xiaowu Authors:Lixing Zhou, Ying Cheng, Wanyu Zhao, Xuelian Sun, Fengjuan Hu, Meiling Ge, Yan Zhang, Gongchang Zhang, Birong Dong, Xiaolei Liu

Bevacizumab (Bev) resistance limits therapeutic efficacy in ovarian cancer (OC) patients. We identified ESM1 as a key gene in Bev-resistant OC. ESM1 secreted by OC-resistant cell lines activates the ITGB1/FAK axis to induce neovascularization and Bev resistance. Additionally, ESM1 overexpression promoted the growth and Bev resistance of OC, lung, intestinal, and hepatocellular carcinoma tumors. Then, we identified TRIM28 as an upstream regulator that stabilizes ESM1 by promoting SUMOylation, inhibiting its proteasomal degradation. In OC mice, TRIM28 overexpression promotes angiogenesis and Bev resistance via ESM1-mediated ITGB1/FAK activation. This work unveils a new molecular pathway underlying Bev resistance in OC and proposes TRIM28 and ESM1 as potential therapeutic targets.

Authors:Jun Liao, Mengzhen Wei, Jianjun Wang, Jinsong Zeng, Danhong Liu, Qiusi Du, Jinwen Ge, Zhigang Mei

Background Xin-tong-tai Granule (XTTG), a traditional Chinese medicine, has been used to treat atherosclerosis (AS), but its mechanism is poorly understood. Intriguingly, oxidative stress has been recognized as vital factors in the treatment of atherosclerosis. Purpose This study aims to explore the potential mechanism of XTTG for treating AS. Methods An in-vivo model of AS was established by feeding ApoE -/- mice with a high-fat diet (HFD), and the Human Aortic Vascular Smooth Muscle Cells (HAVSMCs) were induced by oxidized low-density lipoprotein (ox-LDL) in vitro. After treatment, the blood lipid levels and pathological aortic changes of each group were observed, and the cell proliferation and lipid droplet aggregation in each group were evaluated. The oxidative stress indicators such as malondialdehyde (MDA) and superoxide dismutase (SOD) levels and related NOX/ROS/NF-κB signaling pathway indicators were observed. Results XTTG improved blood lipid levels and pathological aortic changes of ApoE −/− mice with HFD feeding, inhibited HAVSMCs proliferation and lipid droplet aggregation induced by ox-LDL, reduced MDA content, increased SOD content, inhibited NOX4 and p22phox protein expression, downregulated ROS content, inhibited IKK-α, IKK-β, NF-κB protein and mRNA expression and the phosphorylation of NF-κB. Conclusion XTTG can inhibit NOX/ROS/NF-κB signaling pathway, reduce damages caused by oxidative stress, and exert anti-AS effects.

Authors:Jia-ming Wei, Hui Yuan, Cheng-xin Liu, Zi-yan Wang, Min Shi, Zhi-hua Guo, Ya Li Journal of Translational Medicine IF:7.5 Authors:Lu Tailiang, Shen Guodong, Huang Tao, Mao Xinyuan, He Junting, Hu Yanfeng

相关资料下载:说明书(.pdf)(点击从官网下载)

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

规格100T 250T 500T 2500T BCA蛋白定量试剂盒
附表(常见干扰物质的上限浓度)化合物浓度化合物浓度NP-401.0%葡萄糖10mMSDS1.0%蔗糖1M盐酸胍4MEDTA10mMTrition X-1001%β-巯基乙醇50μM甘氨酸1MDTT1mM乙酸盐0.2M尿素3MTris0.1MDMSO5%NaCl1M甘油10%HCl/NaOH0.1MTES50mMHEPES0.1MMOPS50mM
注意1.本产品仅供科研使用。请勿用于医药、临床诊断或治疗。食品及化妆品等用途。请勿存放于普通住宅区。2.为了您的安全和健康,请穿好实验服并佩戴一次性手套和口罩操作。3.实验结果可由多种因素影响,相关处理只限于产品本身,不涉及其他赔偿。
BCA-A20ml
50ml100ml
500mlRT
BCA-B0.6ml
5ml3ml
15mlRT
1ml2ml
10ml2-8℃
编号稀释液用量(μl)
BSA标准品用量(μl)BSA标准品最终浓度(μg/μl)
A0
B200
C200
200(从B管取)0.5
D200
200(从C管取)0.25
E200
200(从D管取)0.125
F200
200(从E管取)0.0625
G200

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2016 年
所在地
湖南
收录条目
498 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

艾碧维 原厂
Abiowell

进入企业主页
498 本目录条目
产地 / 总部湖南省长沙高新区
成立年份2016 年
本目录主营蛋白与抗体 / 生化试剂 / 细胞生物学 / 分子生物学

公司产品涵盖抗体、细胞、培养基、质粒载体等多个领域,致力于为生命科学研究提供可靠的工具与解决方案。自创立以来,艾碧维始终秉持“求实、诚挚、勤勉、克己”的发展理念,坚持以自主研发与持续创新为核心动力。公司拥有百余人的团队,其中硕士及以上学历生物医学专业人才占比超过30%,包括博士4人,构建起一支结构合理、专业扎实的研发与服务队伍。通过设立研发部、生产部、市场与营销部、财务部等多功能部门,公司实现了从产品开发到市场推广的全流程管控。艾碧维不仅敢于质疑现状,积极为生命科学家突破技术壁垒提供支撑,更注重与客户的深度互动与合作,通过持续收集反馈、开展研发协作,提前预见并解决潜在问题。未来,公司将继续秉持“助力科研创新,让实验更简单”的使命,一步一个脚印地打造具有国际领先水平的技术研发与产业化平台,为全球生命科学领域的进步持续赋能。注意: 1.本公司产品仅供科研使用。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-10-31
科研在线(TeleVM). BCA蛋白定量试剂盒(AWB0104)[EB/OL]. 产品目录, 2026-10-31. https://www.suprotek.cn/products/item/awb0104.html.
TeleVM. (2026, October 31). BCA蛋白定量试剂盒(AWB0104). 产品目录. https://www.suprotek.cn/products/item/awb0104.html
@misc{biocsp_item_awb0104,
  title        = {BCA蛋白定量试剂盒(AWB0104)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-10-31,产品目录},
  url          = {https://www.suprotek.cn/products/item/awb0104.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

BCA蛋白定量试剂盒

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。